We found that CNS and PNS tumors exhibited the lowest expression of VRK2 across all tumor lineages, while VRK1 expression was slightly reduced in CNS/PNS tumors as compared with all other tumor lineages (Supplemental Figure 4, A and B). This evidence concerns the gene VRK2 and neoplasm.